All News

Pfizer to sell consumer healthcare businesses to J&J

Arcadia Resources, a provider of home care and staffing services and respiratory and durable medical equipment, has formed a partnership with Physicians' Organization of Western Michigan, a 570-member independent physicians' coalition based in the state. Through POWM's partnership with Meijer, plans are moving forward to open walk-in medical clinics inside select Meijer stores in Indiana.

Dispensing Solutions Inc. (DSI), a Santa Ana, Calif.-based leader in repackaged pharmaceuticals, has launched a drug pedigree program. The program will be implemented nationally for all DSI product lines.

Until now, Novartis Corp.'s Exelon (rivastigmine tartrate) was approved to treat mild to moderate dementia associated with Alzheimer's disease. Now the drug has gained a new indication-to treat mild to moderate dementia related to Parkinson's disease.

The Healthcare Distribution Management Association (HDMA) is partnering with RxPatrol to combat the theft and illegal trafficking of prescription medications and further enhance supply chain security. RxPatrol is an information clearinghouse designed to collect, analyze, and share information on pharmacy robberies, burglaries, and theft of controlled substances.

After being shot down by the state commission on higher education last year, the University of South Alabama (USA) is reworking plans for a new pharmacy school. USA is in talks with Auburn University officials about some type of satellite collaboration on its campus in Mobile.

OK, now it's official. Providing annual vaccination against the flu for staff in hospitals and nursing homes will be a JCAHO standard as of Jan. 1, 2007.

Saddle River Marketing Concepts has earned the Verified-Accredited Wholesale Distributors accreditation offered by NABP to secure the integrity of the nation's drug supply. The New Jersey-based firm fulfills Rx samples to physicians and trade pack orders for patient assistance programs.

ASHP and the ASHP Research and Education Foundation unveiled plans to establish a center for health-system pharmacy leadership by the end of this year. The center will be a division of the ASHP Research and Educational Foundation and will be located in the organizations headquarters in Bethesda, MD.

The pharmacy at a Kmart in Helena, Mont., is launching its first Coumadin (warfarin sodium, Bristol-Myers Squibb) clinic. Pharmacists at the store have been certified to test the blood of patients who are taking the blood-thinning medicine.

The American Pharmacy Cooperative (APCI), a Bessemer, Ala.-based independent community pharmacy buying group with more than 1,200 members in 20 states, has entered into a cooperative marketing agreement with Vital Care, Meridian, Miss. The purpose of the agreement is to make it possible for members of APCI to evaluate the practicality of getting into the home infusion and specialty market with a Vital Care franchise.

The FDA is warning consumers not to use the Triaminic Vapor Patch marketed by Novartis Consumer Health due to reports of serious adverse events associated with accidental ingestion by children. The patch contains camphor, eucalyptus oil, and menthol.

More people initiated nonmedical use of narcotic pain relievers in the past year than initiated use of marijuana or cocaine. This finding comes from a new report from the Substance Abuse & Mental Health Services Administration (SAMHSA) that extracted data from the 2004 National Survey on Drug Use and Health.

A total of 185 Web sites now sell controlled substances, up from 154 in 2004, according to a survey by the National Center on Addiction & Substance Abuse (CASA). Only 11% of the sites require a prescription. Of the 165 sites that don't require an Rx, 30% advertised that no script was needed, 60% offered on-line consultations, and 10% didn't mention a prescription.

Pharmacists dialing the dedicated Medicare Part D help line will now be redirected to the 1-(800) MEDICARE interactive voice response system instead. CMS pulled the plug on the R.Ph.-only help line after daily calls fell by 80% since Jan. 1.

A study conducted by S/T Health Group, an independent healthcare consulting firm, found that McKesson customers experience the lowest percentage of contract price errors in the industry. McKesson officials asserted that the study data affirmed that the San Francisco-based drug wholesaler continues to lead the pharmaceutical wholesale industry in contract price accuracy.

Zars Pharma has announced the launch of Synera (lidocaine 70 mg/tetracaine 70 mg), a topical patch approved for the prevention of pain associated with superficial venous access and superficial dermatological procedures such as excision, electrodessication, and shave biopsy of skin lesions in patients four months of age and older. Zars Pharma has licensed Synera to Endo Pharmaceuticals for sales and marketing in North America. According

A new bill, S. 3546-the Dietary Supplement & Non-Prescription Drug Consumer Protection Act-has been introduced. If passed, the bill will amend the Food, Drug & Cosmetic Act to require the reporting of "serious" adverse events by manufacturers for both OTCs and dietary supplements to the FDA.

SmartCare Family Medical Centers, a Colorado-based operator of healthcare centers, announced an agreement to lease space within select Wal-Mart Supercenters in Arizona, Colorado, and Nevada. SmartCare Centers offer care for common ailments such as sore throats, ear infections, and seasonal allergies, as well as flu shots and other vaccines, school and employment physicals, and cholesterol screenings.

ASHP has joined the Alliance for Cardiac Care Excellence (ACE), a coalition of healthcare organizations committed to improving care for cardiac patients through the use of nationally accepted standards. The coalition will focus on implementing seven quality measures, including the administration of aspirin to patients arriving at the hospital with symptoms of a heart attack, the prescribing of beta-blockers to heart attack patients at discharge, and the use of ACE inhibitors to treat left ventricular systolic dysfunction.

The healthcare accreditation organization URAC has formed a committee to consider creation of the first accreditation program for PBMs. The chairman of the URAC PBM quality standards committee is John Jones, R.Ph., J.D., VP-government affairs and pharmacy policy at the PBM Prescription Solutions.

Longs Drug Stores has purchased the assets of Network Pharmaceuticals, including 21 retail pharmacies, one wholesale pharmacy, and one closed-door pharmacy, for about $10 million plus inventory. The retail pharmacies are located within or near medical office buildings, clinics, and hospitals.

Communicating with patients about Part D consumes an average 1.5 hours according to physicians surveyed by the J. Scott Group. The physicians estimated Part D generates an additional five phone calls per day from pharmacists requesting a switch to a cheaper drug or one on a patient's formulary.

America's Health Insurance Plans pledged to work with PBMs to ensure that payment for clean Part D claims is sent electronically or by mail at least twice monthly and no later than 30 days after the claims are submitted by the pharmacy. The industry will also work with PBMs and pharmacy to promote the availability and use of electronic funds transfer for Rx claims.

A report on lessons learned from KatrinaHealth, the collaborative effort to post secure, on-line information about the Rx drug histories of Hurricane Katrina evacuees, has been posted at http://katrinahealth.org/katrinahealth.final.pdf. The Merkle Foundation's report urges the government and private sector to work together to put in place systems, technologies, and policies to ensure that information is readily available to patients and providers when disaster strikes.

MedVantx, a network promoting use of generics and OTC samples in physician offices, has acquired AmeriPharm, a pharmacy service company based in Sioux Falls, S.D. AmeriPharm will provide central distribution and automated medication replenishment for MedVantx' point-of-care Sample Center.

Wellbutrin XL (bupropion HCl extended-release tablets) from GlaxoSmithKline has been approved for the prevention of major depressive episodes in patients with a history of seasonal affective disorder (SAD) and is the first drug approved for this indication, the FDA said at a press conference. The depressive episodes associated with SAD can last up to six months and tend to occur during the autumn and winter, when daylight hours are at a minimum.